Most COVID-19 vaccinees had an anti-S1 IgG titre of 100 (33.68%), followed by 200 (29.47%), while 17.89% of vaccinated subjects had an anti-S1 IgG titre below 100 (Figure 3E). The gene discussed is PSMD1; the disease is COVID-19.